BioRegenerative Sciences, Inc. Observes World Menopause Day
BioRegenerative Sciences in observance of World Menopause Day, October 18, 2012, will offer a special price on their Feminease product for Feminine Dryness. World Menopause Day is sponsored by the World Health Organization (WHO) and the International Menopause Society (IMS). According to WHO, the average age of menopause is 51, and over 1 billion women will be over the age of 50 by 2025. As the population ages, women need to be given the resources and tools to prepare them for menopause.
San Diego, CA, October 15, 2012 --(PR.com)-- BioRegenerative Sciences, Inc., (BRS), a privately owned stem cell therapeutics corporation headquartered in San Diego, CA, USA, announced today that in observance of World Menopause Day on October 18, 2012, BRS will offer a special price on their Feminease product for Feminine Dryness. World Menopause Day is sponsored by the World Health Organization (WHO) and the International Menopause Society (IMS). According to WHO, the average age of menopause occurs at 51, and over 1 billion women will be over the age of 50 by 2025. As the population ages, it is important women are given the resources and tools to prepare them for menopause.
The specially priced Feminease, a topically applied creme for relieving the pain and irritation associated with femine dryness, is one of BRS’ several products that will help relieve some of the problems associated with menopause. Other products include I-Ease eye drops for the relief of discomfort related to Dry Eye, Hair Stemulating Complex for loss of hair, and Vital Serum and the BRS line of cosmeceutical products for dry skin.
Dr. Rita Friedman, Scientific Advisory Board member at BioRegenerative Sciences said, “Feminease is formulated using BRS’s core technology where the molecules from multiple stem cell types are used to mimic the natural healing and growth processes of the human body. Our S2RM TM nourishes the tissue and the stem cell niche helping to relieve the unwanted dryness.” Debra McCarthy, R.N., Scientific Advisory Board member at BioRegenerative Sciences, added “Feminease is a scientific shift from conventional treatment options that promotes the natural lubrication of tissue, and provides long term relief by enabling our own spontaneous healing mechanisms.”
Feminease is already available to consumers, and may be purchased at www.bioregenerativesciences.com. For more information, please email: sales@bioregenerativesciences.com, or call customer service at 877.892.9991.
The specially priced Feminease, a topically applied creme for relieving the pain and irritation associated with femine dryness, is one of BRS’ several products that will help relieve some of the problems associated with menopause. Other products include I-Ease eye drops for the relief of discomfort related to Dry Eye, Hair Stemulating Complex for loss of hair, and Vital Serum and the BRS line of cosmeceutical products for dry skin.
Dr. Rita Friedman, Scientific Advisory Board member at BioRegenerative Sciences said, “Feminease is formulated using BRS’s core technology where the molecules from multiple stem cell types are used to mimic the natural healing and growth processes of the human body. Our S2RM TM nourishes the tissue and the stem cell niche helping to relieve the unwanted dryness.” Debra McCarthy, R.N., Scientific Advisory Board member at BioRegenerative Sciences, added “Feminease is a scientific shift from conventional treatment options that promotes the natural lubrication of tissue, and provides long term relief by enabling our own spontaneous healing mechanisms.”
Feminease is already available to consumers, and may be purchased at www.bioregenerativesciences.com. For more information, please email: sales@bioregenerativesciences.com, or call customer service at 877.892.9991.
Contact
BioRegenerative Sciences, Inc.
Dr. Greg Maguire
858.413.7372
www.bioregenerativesciences.com
Dr. Greg Maguire
858.413.7372
www.bioregenerativesciences.com
Contact
Categories